6.
Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K
. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5.
DOI: 10.1161/CIRCULATIONAHA.109.192644.
View
7.
Allagnat F, Christulia F, Ortis F, Pirot P, Lortz S, Lenzen S
. Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis. Diabetologia. 2010; 53(6):1120-30.
DOI: 10.1007/s00125-010-1699-7.
View
8.
Anttonen A, Mahjneh I, Hamalainen R, Lagier-Tourenne C, Kopra O, Waris L
. The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet. 2005; 37(12):1309-11.
DOI: 10.1038/ng1677.
View
9.
Ash P, Bieniek K, Gendron T, Caulfield T, Lin W, DeJesus-Hernandez M
. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013; 77(4):639-46.
PMC: 3593233.
DOI: 10.1016/j.neuron.2013.02.004.
View
10.
Athauda D, Foltynie T
. Insulin resistance and Parkinson's disease: A new target for disease modification?. Prog Neurobiol. 2016; 145-146:98-120.
DOI: 10.1016/j.pneurobio.2016.10.001.
View
11.
Atkin J, Farg M, Walker A, McLean C, Tomas D, Horne M
. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis. 2008; 30(3):400-407.
DOI: 10.1016/j.nbd.2008.02.009.
View
12.
Aviles-Olmos I, Limousin P, Lees A, Foltynie T
. Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain. 2012; 136(Pt 2):374-84.
DOI: 10.1093/brain/aws009.
View
13.
Baek J, Mamula D, Tingstam B, Pereira M, He Y, Svenningsson P
. GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson's Disease Patients. Front Neurosci. 2019; 13:697.
PMC: 6624451.
DOI: 10.3389/fnins.2019.00697.
View
14.
Baleriola J, Walker C, Jean Y, Crary J, Troy C, Nagy P
. Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell. 2014; 158(5):1159-1172.
PMC: 4149755.
DOI: 10.1016/j.cell.2014.07.001.
View
15.
Banks W
. The source of cerebral insulin. Eur J Pharmacol. 2004; 490(1-3):5-12.
DOI: 10.1016/j.ejphar.2004.02.040.
View
16.
Bellucci A, Navarria L, Zaltieri M, Falarti E, Bodei S, Sigala S
. Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. J Neurochem. 2010; 116(4):588-605.
DOI: 10.1111/j.1471-4159.2010.07143.x.
View
17.
Bernard-Marissal N, Sunyach C, Marissal T, Raoul C, Pettmann B
. Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice. Neurobiol Dis. 2014; 73:130-6.
DOI: 10.1016/j.nbd.2014.09.009.
View
18.
Biessels G, Reagan L
. Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci. 2015; 16(11):660-71.
DOI: 10.1038/nrn4019.
View
19.
Biessels G, Staekenborg S, Brunner E, Brayne C, Scheltens P
. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2005; 5(1):64-74.
DOI: 10.1016/S1474-4422(05)70284-2.
View
20.
Bikman B, Summers S
. Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest. 2011; 121(11):4222-30.
PMC: 3204836.
DOI: 10.1172/JCI57144.
View